Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in combination ...

As Chair of the Scientific Advisory Committee, Dr. Lewis-Hall will provide leadership in scientific, clinical, and regulatory governance across Helus' portfolio, advising on discovery opportunities, ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsAndrew Guggenhime - President & CFOGrant Pickering ...

Moderna has announced that the FDA will initiate the review of its seasonal influenza vaccine candidate, mRNA-1010.

A former Senior Special Adviser on Industrialisation to the President of the African Development Bank, Professor Banji Oyelaran-Oyeyinka, has released a new book, The Quest for Industrialisation: ...

By Stine Jacobsen and Louise Rasmussen COPENHAGEN, Feb 20 (Reuters) - Novo Nordisk will nominate drug industry veterans Jan ...

Pfizer’s Albert Bourla put it more bluntly in Davos last month, saying it’s a “different world when you start discussing ...

"Devyn brings a rare combination of scientific depth, operational leadership, and strategic perspective," said Nazli Azimi, Ph.D., Chief Executive Officer of Therna. "His experience across genetic ...

Dr. Paul Bunge begins his new book about COVID-19 by inviting readers to join him on a journey — one he knows will be uncomfortable, perhaps even full of disagreements. Bunge, a former U.S.

Q. My husband got COVID last fall. He has had great success from Paxlovid in the past, when he got it for free during the pandemic. This time he was charged $800 on his Medicare Drug Plan. That seems ...

Mental health disorders--including depression, anxiety, PTSD, and bipolar disorder--continue to represent one of the largest and fastest-growing ...